Pharmac Notification: Decision not to proceed with proposed changes to Options for Investment list
- admin82291
- 10h
- 1 min read
Following feedback, Pharmac has decided not to proceed with a proposal to decline some low-ranked applications on the Options for Investment (OFI) list.
We heard from a wide range of people - clinicians, professional groups, patient advocates, individuals and pharmaceutical companies.
People told us that while they understood our aim was to improve transparency, they did not want us to remove funding applications from the OFI.
We’ve listened carefully and appreciate the time and thought that went into this feedback.
Because of what we’ve heard, we will not proceed with the proposal. At this stage, we are not proposing any changes to how Pharmac manages the OFI list.
Improving transparency and timeliness of the medicine funding application process remains a focus for Pharmac and our Consumer and Patient Working Group. Broader work is now underway as part of the Reset Programme, focusing on improvements to the current process and potential future changes.
We are committed to engaging meaningfully with consumers, clinicians, suppliers, and the wider public. If a new proposal comes from this work, we will consult again.
Ngā mihi,
Jayne Watkins | Principal Advisor, Pharmaceutical Funding TeamPharmac | Te Pātaka Whaioranga | P: 0800 660 050 | www.pharmac.govt.nz
